Search
for
Sort by
Research 121–150 of 1000+
- A narrative review of SARS-CoV-2 variants and long COVID
- Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods
- In silico screening of Moroccan medicinal plants with the ability to directly inhibit the novel coronavirus, SARS-CoV-2
- Androgen sensitivity gateway to COVID‐19 disease severity
- The Double Edge Sword of Testosterone’s Role in the COVID-19 Pandemic
- Testosterone in COVID-19: An Adversary Bane or Comrade Boon
- The secret identities of TMPRSS2: Fertility factor, virus trafficker, inflammation moderator, prostate protector and tumor suppressor
- Cepharanthine: A review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- Letter to the Editor on “COVID-19 Infection in Men on Testosterone Replacement Therapy”
- Editor's Picks August 2023
- Immuno-Endocrinology of COVID-19: The Key Role of Sex Hormones
- Protective trend of anti-androgen therapy during the COVID-19 pandemic: A meta-analysis
- Molecular Mechanisms Lead to Sex-Specific COVID-19 Prognosis and Targeted Therapies
- Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- Antiviral and Anti-Inflammatory Plant-Derived Bioactive Compounds and Their Potential Use in the Treatment of COVID-19-Related Pathologies
- DEVELOPING NEW DUAL-ACTION ANTIVIRAL/ANTI-INFLAMMATORY SMALL MOLECULES FOR COVID-19 TREATMENT USING IN SILICO AND IN-VITRO APPROACHES
- Therapeutics for COVID-19 and post COVID-19 complications: An update
- Evaluating the Metabolomic Profile and Anti-Pathogenic Properties of Cannabis Species
- Research and development of Chinese anti-COVID-19 drugs
- Pharmacological Activity of Cepharanthine
- Androgens in SARS-CoV-2 Coronavirus Infections
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- SARS‐CoV‐2‐induced telogen effluvium: a multicentric study
- Telogen Effluvium after SARS-CoV-2 Infection: A Series of Cases and Possible Pathogenetic Mechanisms
- Targeting host cell proteases as a potential treatment strategy to limit the spread of SARS‐CoV‐2 in the respiratory tract
- The Experience of SARS-CoV-2 in Patients with Benign Prostatic Hyperplasia: Is There Any Correlation between Them?
- TMPRSS2: A Key Host Factor in SARS-CoV-2 Infection and Potential Therapeutic Target
- Role of ACE2 polymorphism in COVID-19: impact of age
- Hypochlorous Acid: Clinical Insights and Experience in Dermatology, Surgery, Dentistry, Ophthalmology, Rhinology, and Other Specialties
- ВЛИЯНИЕ АНДРОГЕННОГО СТАТУСА И АНТИАНДРОГЕННОЙ ТЕРАПИИ НА ТЕЧЕНИЕ COVID-19 У МУЖЧИН